CDER director Tidmarsh will be acting head of FDA biologics center following Prasad exit

The FDA’s new top drug regulator will also serve as acting director of the agency’s biologics center now that Vinay Prasad has departed, an FDA spokesperson told Endpoints News. George Tidmarsh, a former biotech industry ...